Allworth Financial’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3
Closed -$1 3603
2023
Q2
$1 Hold
3
﹤0.01% 3248
2023
Q1
$5 Hold
3
﹤0.01% 3167
2022
Q4
$6 Hold
3
﹤0.01% 2971
2022
Q3
$0 Hold
3
﹤0.01% 3282
2022
Q2
$0 Hold
3
﹤0.01% 2978
2022
Q1
$0 Hold
3
﹤0.01% 2477
2021
Q4
$0 Hold
3
﹤0.01% 2198
2021
Q3
$0 Hold
3
﹤0.01% 2016
2021
Q2
$0 Hold
3
﹤0.01% 1711
2021
Q1
$0 Buy
+3
New +$209 ﹤0.01% 1658
2020
Q2
Sell
-3
Closed 1418
2020
Q1
$0 Buy
+3
New +$314 ﹤0.01% 1358

Other funds holding SRGA

Allworth Financial's SRGA Position: Q3 2023 in Review

Allworth Financial sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 3 shares — an estimated $1 sold.

Allworth Financial first reported a position in SRGA in Q1 2020 and held it in 11 quarters. The position peaked at $6 in Q4 2022. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.

  • Allworth Financial reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Allworth Financial sold 3 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $1.
  • Allworth Financial first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Allworth Financial's Surgalign Holdings, Inc. Common Stock position peaked at $6 in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.

Based on Allworth Financial's 13F filing for Q3 2023, filed 31 Oct 2023.